Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Status:
RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
Main Purpose of this study is to determine the efficacy and safety of Cadonilimab combined with chemotherapy (cisplatin) for locally advanced cervical cancer.
This is an multicentre, single Arm, Phase 2 Trial study of Cadonilimab with Cisplatin in the treatment of locally advanced cervical cancer. 29 eligible patients will receive Cadonilimab10mg/kg, iv., D1, q3wwith Cisplatin ( 75mg/ m2, iv., D2 q3w) for a total of 2-4 cycles before radical surgical treatment.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Henan Provincial People's Hospital Second Affiliated Hospital of Zhengzhou University